Josef Mysliwietz
- LSC 2012 abstract - Effects of the Hedgehog (Hh) pathway inhibitor GDC-0449 on lung cancer cells and cisplatin resistant lung cancer cells are mediated by lung cancer stem cells (SPs)By Fei Tian, Josef Mysliwietz, Joachim Ellwart, Amanda Tufman, Albrecht Bergner and Rudolf HuberFei Tian1Division of Respiratory Medicine, Medizinische Klinik-Innenstadt, Ludwig-Maximilians-University, Munich, GermanyJosef Mysliwietz2Hämatologikum, HelmholtzZentrum, German Research Center for Environmental Health, Munich, GermanyJoachim Ellwart2Hämatologikum, HelmholtzZentrum, German Research Center for Environmental Health, Munich, GermanyAmanda Tufman1Division of Respiratory Medicine, Medizinische Klinik-Innenstadt, Ludwig-Maximilians-University, Munich, GermanyAlbrecht Bergner1Division of Respiratory Medicine, Medizinische Klinik-Innenstadt, Ludwig-Maximilians-University, Munich, GermanyRudolf Huber1Division of Respiratory Medicine, Medizinische Klinik-Innenstadt, Ludwig-Maximilians-University, Munich, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.